Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07155213 · ClinicalTrials.gov registry record · Early Phase 1

Adapted High-Intensity Virtual Reality Exergaming

A Early Phase 1 study of Cerebral Palsy, sponsored by University of Alabama at Birmingham.

Active
Registry status
Early Phase 1
Development phase
4
Enrollment target
1
Study location

NCT07155213: Active Early Phase 1 study of Cerebral Palsy, sponsored by University of Alabama at Birmingham.

NCT07155213 is a Early Phase 1 study of Cerebral Palsy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 4 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07155213, a Early Phase 1 study of Cerebral Palsy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program includes head-mounted displays (Meta Quest) and off-the-shelf games.

Primary Outcome

lbs

Conditions Studied

Interventions

  • BEHAVIORAL Virtual reality exergaming

Study Locations (1)

Alabama

  • UAB Wellness Health and Research Facility - Birmingham

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2025-09-03
Est. Completion 2026-04-01
Phase Early Phase 1
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT07155213 still lists

NCT07155213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Virtual reality exergaming is the first listed.

NCT07155213 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT07155213 about?

NCT07155213 is a clinical study titled "Adapted High-Intensity Virtual Reality Exergaming". This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program i...

What is the current status of trial NCT07155213?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2025-09-03. Estimated completion is 2026-04-01.

What conditions does trial NCT07155213 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT07155213?

The interventions under investigation include: Virtual reality exergaming (BEHAVIORAL).

Who is sponsoring clinical trial NCT07155213?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07155213 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07155213's enrollment target sits among peer trials

4 89th of 91 higher than 1 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07155213, the US trial registry maintained by the National Library of Medicine. NCT07155213 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.